Skip to main content
Clinical Trials/IRCT20231227060538N1
IRCT20231227060538N1
Not yet recruiting
Phase 3

Investigating and comparing the effect of three therapeutic methods of Naproxen, hydroxyzine and Syrup Noscough as therapeutic methods for treatment of the bone pain caused by granulocyte-colony stimulating factor(GCSF) in cancer patients

Shahid Beheshti University of Medical Sciences0 sites123 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
123
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with solid tumor or lymphoma Candidate for receiving Pegfilgrastim \-after chemotherapy based on well known chemotherapy protocol

Exclusion Criteria

  • Bone metastasis in patients with progression free survival(PFS )greater than 2
  • Test\-proven osteomalacia
  • chronic kidney disease or end stage renal disease patients
  • Patients with active rheumatic disease
  • Uncontrolled thyroid disease
  • Patients receiving chemotherapy drugs in which bone pain is one of the complications with a high incidence of 10% (TAXAN family, bisphosphonate.)
  • Patients with pathological fracture or fracture due to any other reason
  • Opioid addicts
  • Contraindications for taking naproxen and methadone and other similar drugs
  • Vitamin D level less than 20

Outcomes

Primary Outcomes

Not specified

Similar Trials